Japanese Researchers to Test Blood Thinner For Virus Treatment
- Generic drug is already approved for use and sold in Japan
- Shares of drugmaker jump on news by university researchers
This article is for subscribers only.
We’re tracking the latest on the coronavirus outbreak and the global response. Sign up here for our daily newsletter on what you need to know.
A blood thinner used to treat pancreatitis and kidney disease has been identified as a potential therapy for coronavirus patients, with clinical trials in Japan possibly set to begin within a month, researchers at the University of Tokyo said Wednesday.